Reach Us +1-217-403-9671
Editor - Pavan Balabathula | The University of Tennessee Health | 14311
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Pavan Balabathula

Pavan Balabathula
Department of Pharmaceutical Sciences
University of Tennessee Health Science Center


Pavan Balabathula is currently working as a Senior Research Specialist in Pharmaceutical Sciences Department at University of Tennessee Health Science Center, Memphis, TN. He conducts research and analytical studies for development of novel drug products according to federal guidelines, which includes formulation development of sterile dosage forms for new chemical entities for pre-clinical and Phase I studies, analytical studies involving drug product testing & stability testing using HPLC, UV-VIS, & DLS. He also develops and validates stability indicating assays in accordance to federal and international guidelines. He is experienced in formulation development of API delivery systems including iron oxide nanopartilces, liposomes, micelles, and solid lipid nanoparticles for treating life threatening cancer and infectious diseases.

Research Interest

Analytical Method Development and Validation. Formulation development of nanotechnology drug delivery systems including iron oxide nanoparticles. Liposomes, micelles, and solid lipid nanoparticles, both targeted and non-targeted.



Global Speakers in the subject

Global Experts in the subject